Lupus nephritis: classification, clinical features, and treatment.
Weissleder
R
R
Galarza
D A
DA
Garza
M A
MA
D001327:Autoimmune Diseases / Q000188:drug therapy / Q000473:pathology; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D008181:Lupus Nephritis / Q000145:classification / Q000473:pathology / Q000628:therapy; D008221:Lymphoid Tissue / Q000528:radiation effects; D008775:Methylprednisolone / Q000627:therapeutic use; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone